- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-346/21: Action brought on 23 June 2021 — Hecht Pharma v EUIPO — Gufic Biosciences (Gufic)
ECLI:EU:UNKNOWN:62021TN0346
62021TN0346
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
16.8.2021
Official Journal of the European Union
C 329/36
(Case T-346/21)
(2021/C 329/47)
Language in which the application was lodged: German
Parties
Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Gufic Biosciences Ltd. (Mumbai, India)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: EU word mark Gufic — EU trade mark No 8 613 044
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 3 June 2021 in Case R 2738/2019-2
Form of order sought
The applicant claims that the Court should:
—annul the contested decision and also declare EU trade mark No 8 613 044 ‘Gufic’ revoked in respect of Class 5 ‘Medicines’;
—order Gufic Biosciences Ltd. to pay the costs of the appeal proceedings and of the pre-litigation procedure.
Plea in law
—Infringement of Article 58(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.